Atlas Trials

FDGL Dose-Finding Study for Diabetic Neuropathy

Clinical trial NCT07117942 · COMPLETED

Trial details

NCT number
NCT07117942
Sponsor
Helwan University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Neuropathy
Start date
2020-02-12
Primary completion
2021-06-18
Enrollment
485

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.